Evidence map›Paper›PMID 40823443›Full record

ArticleSSM. Qualitative research in health2023

Interrogating perceived relevance and feasibility of HIV pre-exposure prophylaxis: A novel model of PrEP acceptability among cisgender women who inject drugs.

Leanne Zhang, Joseph G Rosen, Lyra Cooper, Praise F Olatunde, Danielle Pelaez, Susan G Sherman, Ju Nyeong Park, Jennifer L Glick

Abstract read
In one paragraph

Article in SSM. Qualitative research in health, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Leanne ZhangDepartment of Health, Behavior, and Society, Bloomberg School of Public Health, Johns Hopkins University, 624 N Broadway Rm 280, Baltimore, MD, 21205, USA.
Joseph G RosenDepartment of International Health, Bloomberg School of Public Health, Johns Hopkins University, 615 N Wolfe St Rm E8527, Baltimore, MD, 21205, USA.
Lyra CooperDepartment of Health, Behavior, and Society, Bloomberg School of Public Health, Johns Hopkins University, 624 N Broadway Rm 280, Baltimore, MD, 21205, USA.
Praise F OlatundeDepartment of International Health, Bloomberg School of Public Health, Johns Hopkins University, 615 N Wolfe St Rm E8527, Baltimore, MD, 21205, USA.
Danielle PelaezDepartment of Health, Behavior, and Society, Bloomberg School of Public Health, Johns Hopkins University, 624 N Broadway Rm 280, Baltimore, MD, 21205, USA.
Susan G ShermanDepartment of Health, Behavior, and Society, Bloomberg School of Public Health, Johns Hopkins University, 624 N Broadway Rm 280, Baltimore, MD, 21205, USA.
Ju Nyeong ParkDepartment of Health, Behavior, and Society, Bloomberg School of Public Health, Johns Hopkins University, 624 N Broadway Rm 280, Baltimore, MD, 21205, USA.
Jennifer L GlickDepartment of Health, Behavior, and Society, Bloomberg School of Public Health, Johns Hopkins University, 624 N Broadway Rm 280, Baltimore, MD, 21205, USA.

Funding

Vaccine Response and Immunotherapeutics SWGP30AI094189 · NIAID · JOHNS HOPKINS UNIVERSITY · PI Anna Palmer Durbin · 2012 to 2026
$67.0M
Project 4: Neonatal Abstinence Syndrome (NAS): Fetus to First YearsP20GM125507 · NIGMS · RHODE ISLAND HOSPITAL · PI Brandon David Lewis Marshall · 2018 to 2026
$23.4M
Viral Load Trajectories and Dynamics among People Living with HIV in Rakai, Uganda: A Mixed-Methods StudyF31MH126796 · NIMH · JOHNS HOPKINS UNIVERSITY · PI ROSEN, JOSEPH GREGORY · 2021 to 2022
$79k
NIAID NIH HHS P30 AI094189NIGMS NIH HHS P20 GM125507NIMH NIH HHS F31 MH126796
6 · The paper itself

Abstract

Introduction: Uptake of daily oral HIV pre-exposure prophylaxis (PrEP) remains low among cisgender women who inject drugs (WWID) in the U.S., who experience elevated sexual- and injection-mediated HIV exposure risks. While anticipated barriers to PrEP uptake have been explored, further work is needed to situate PrEP acceptability (i.e., PrEP interest and willingness) within the context of WWID's lives and the HIV risk environment. Methods: We conducted semi-structured, in-depth interviews (N = 27) with cisgender WWID in Baltimore, Maryland, between April-September 2021. Interviews explored women's daily survival needs, substance use practices, healthcare experiences, HIV risk perception, and PrEP perspectives. Thematic analysis revealed complex dimensions of WWID's health perspectives and HIV risk conceptualization, from which a Psychosocial Model of PrEP Acceptability and a novel construct of 'perceived PrEP relevance' were developed using a grounded theory approach. Results: In our Psychosocial Model of PrEP Acceptability, anticipated PrEP feasibility and perceived PrEP relevance shape women's interest in and willingness to initiate PrEP. Attending to PrEP-related healthcare tasks (e. g., medical appointments, bloodwork) and managing a daily medication regimen were anticipated as feasible but would likely be de-prioritized relative to women's competing substance-related and survival needs. Women's perceptions of both their locus of HIV risk and sufficiency of existing HIV prevention practices determined their perceived PrEP relevance. PrEP was least relevant for women perceiving their prevention practices as sufficient to mitigate self-controlled HIV risk and most relevant for women perceiving their prevention practices as insufficient to mitigate environmentally shaped HIV risk. Conclusions: Our models demonstrate how PrEP acceptability is influenced by WWID's lived experiences and complex risk conceptualization. Effective multilevel interventions to enhance PrEP engagement should support women's competing needs, affirm women's existing prevention strategies, and address the harms of the HIV risk environment.

Indexed as

HIV preventionHIV risk environmentPrEP care continuumQualitative researchSubstance useWomen who inject drugs

Identifiers

PMID40823443
PMCPMC12356171

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.